VivoSim Labs, Inc. (NASDAQ: VIVS) announced it has entered into a securities purchase agreement with a single healthcare-focused institutional investor to raise…
Greenwich LifeSciences (NASDAQ: GLSI) provided an update on its Phase 3 FLAMINGO-01 trial evaluating GLSI-100, an immunotherapy designed to prevent…
Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma's MS focus is Lucid-MS,…
The company has received a Texas DSHS Certificate of Registration for Industrial Radiation Machines, allowing research and development activities involving…
Datavault AI (NASDAQ: DVLT) announced that Fiserv (NASDAQ: FISV) will serve as the exclusive embedded financial services and payments provider for the company's…
Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Multiple sclerosis is one of…
Datavault AI (NASDAQ: DVLT) a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, outlined its strategic…
BOXABL is advancing a factory-based approach to housing that seeks to standardize production and improve cost efficiency in a traditionally…
NUBURU (NYSE American: BURU) announced the closing of its previously announced best-efforts public offering, raising approximately $38.0 million in gross proceeds…
Regentis Biomaterials (NYSE American: RGNT) announced that the Japan Patent Office has issued a Notice of Allowance for a patent covering its…